Bayer | BAYN - Ordinary Share Capital



Bayer reported EUR982.42M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Air Liquide EUR 576.67M 2.6B Jun/2025
Akzo Nobel EUR 171.01M 86.01M Jun/2025
Alcon AG USD 20M 0 Mar/2025
Amarin USD 308.15M 2.85M Mar/2025
Arkema EUR 75.42M 685.58M Jun/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
BASF EUR 892.52M 249.48M Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Beiersdorf EUR 220.21M 27.79M Jun/2025
Corteva USD 679.88M 672.88M Jun/2025
Covestro EUR 188.74M 259.67K Jun/2025
Essilor EUR 456.71M 374.71M Jun/2025
Fresenius EUR 563.24M 237K Jun/2025
Fresenius Medical Care EUR 293.41M 0 Jun/2025
Genmab DKK 10M 56M Mar/2025
Givaudan CHF 92M 0 Jun/2024
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GRIFOLS EUR 680.41M 560.8M Jun/2025
Henkel EUR 413.96M 24.04M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Johnson Matthey GBP 197M 10M Mar/2025
Linde USD 468.91M 467.91M Jun/2025
Lonza CHF 72M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Novartis USD 793M 0 Dec/2024
Nutrien USD 486.87M 13.18B Jun/2025
Philips EUR 950.57M 762.57M Jun/2025
PPG Industries USD 225.7M 743.3M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sanofi 1.22B 36.5M Jun/2025
SAP EUR 1.17B 62.41M Jun/2025
Solvay EUR 104.46M 132.54M Jun/2025
UCB EUR 584M 0 Dec/2024
Umicore EUR 240.56M 1.14B Jun/2025
Vinci EUR 559.63M 895.37M Jun/2025